Research Article| Volume 36, ISSUE 1, P49-55, April 1989

OKY-046 inhibits thromboxane synthesis with no effect on brain edema and neurological status in head traumatized rats

      This paper is only available as a PDF. To read, Please Download here.


      Head trauma (HT) was induced in the left hemisphere of rats by a weight drop device. Edema was maximal 24 h after HT in the injured zone, and PGE2, TXB2 and 6-keto-PGF were elevated in both the injured and remote areas.
      The effect of a specific thromboxane synthetase inhibitor, OKY-046, on the outcome of HT was studied. OKY-046, 100 mg/kg, was given to rats immediately and 8 h after HT. The neurological severity score (NSS) was evaluated at 1 h after HT, and at 24 h, just prior to sacrifice. Specific gravity (SG) of both hemispheres was measured after decapitation. Prostaglandins (PGs) were extracted from the site of injury and from the frontal lobes, remote from the injury, and assayed by RIA. Basal levels of PGE2 and 6-keto-PGF were not reduced by the drug while basal TXB2 levels were lowered. However, the increased production due to HT of all PGs, was inhibited by OKY-046, especially that of TXB2.
      The ratio of Math Eq, known to affect vascular tone, was reduced by OKY-046 treatment as a result of TXA2 synthesis inhibition. Still, no effect was found on the neurological outcome (as evaluated by the NSS), or on edema formation (expressed by reduced SG). Thus, based on the present findings increased TXA2 synthesis cannot be implicated in the pathophysiology of cerebral edema or dysfunction following HT.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Pickard JD
        • Walker V.
        Current concepts of the role of prostaglandins and other eicosanoids in acute cerebrovascular disease.
        in: Mackenzie ET L.E.R.S.vol. 2. Raven Press, New York1984: 191-218
        • Hamberg M
        • Samuelsson B
        Prostaglandin endoperoxides — novel transformation of arachidonic acid in human platelets.
        in: Proc Natl Acad Sci (USA). 71. 1974: 3400-3404
        • Moncada S
        • Vane J.P.
        Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin.
        Pharmacol Rev. 1979; 30: 293-331
        • Kaufman RP
        • Kobzik L.
        • Shepro D
        • Anner H
        • Valeri CR
        • Hechtman H.B.
        Vasodilator prostaglandins (PG) prevent renal damage after ischemia.
        Ann Surg. 1987; 205: 195-198
        • Hallenbeck JM
        • Furlow Jr., TW
        Prostaglandin I2 and indomethacin prevent impairment of post-ischemic brain reperfusion in the dog.
        Stroke. 1979; 10: 629-637
        • Nikolov R
        • Nikolova M
        • Miyares C
        • Milanova D.
        Antihypoxic effect of prostacyclin.
        Meth Find Exptl Clin Pharmacol. 1982; 4: 211-219
        • Nikolov R
        • Nikolova M
        • Georgiev V
        • Gebova D
        • Milanova D.
        Anti-hypoxic effect of centrally and systemically administration of prostacyclin (PGI2).
        Meth Find Exptl Clin Pharmacol. 1984; 6: 691-693
        • Awad I
        • Little JR
        • Lucas F
        • Skrinska V
        • Slugg R
        • Lesser R.P.
        Modification of focal cerebral ischemia by prostacyclin and indomethacin.
        J Neurosurg. 1983; 58 (1983): 714-719
        • Masuda Y
        • Ochi Y
        • Ochi Y
        • Karasaura T
        • Hatama N
        • Kadakana T
        • Okegawa T.
        Protective effect of a new prostacyclin analogue OP-2507 against cerebral anoxia and edema in experimental animals.
        Eur J Pharmacol. 1986; 123: 335-344
        • Masuda Y
        • Ochi Y
        • Ochi Y
        • Karasawa T
        • Hatano N
        • Kadokawa T
        • Shimizu M.
        Protective effect of prostaglandins D2, E1 and I2 against cerebral hypoxia/anoxia in mice.
        Naunyn-Schmiedeberg's Arch Pharmacol. 1986; 334: 282-289
        • Hock CE
        • Brezinski ME
        • Lefer AM.
        Anti ischemic actions of a new thromboxane receptor antagonist, SQ-29548, in acute myocardial ischemia.
        Eur J Pharmacol. 1986; 122: 213-219
        • Hossman K.A.
        Treatment of experimental cerebral ischemia.
        J Cereb Blood Flow Metabol. 1982; 2: 275-297
        • Furlow TV
        • Bass N.H.
        Arachidonate-induced cerebrovascular occlusion in the rat. The role of platelets and aspirin in stroke.
        Neurology (Minneap). 1976; 26: 297-304
        • Boulu RG
        • Gueniav C
        • Plotkine M
        • Sofeir M.
        Recovery from global cerebral ischemia in rabbits: influence of indomethacin.
        Eur Neurol. 1981; 20: 230-234
        • Fredriksson K
        • Rosen I
        • Johansson BB
        • Wieloch T.
        Cerebral platelet thromboembolism and thromboxane synthetase inhibition.
        Stroke. 1985; 16: 800-805
        • Shohami E
        • Shapira Y
        • Sidi A
        • Cotev S.
        Head injury induces increased prostaglandin synthesis in rat brain.
        J Cereb Blood Flow Metab. 1987; 7: 58-63
        • Shohami E
        • Shapira Y
        • Cotev S.
        Experimental closed head injury in rats: Prostaglandins production in a non-injured zone.
        Neurosurg. 1988; (in press)
        • Shapira Y
        • Davidson E
        • Weidenfeld Y
        • Cotev S
        • Shohami E.
        Dexamethasone and indomethacin do not affect brain edema following head injury in rats.
        J Cereb Blood Flow Metabol. 1988; (in press)
        • Shapira Y
        • Shohami E
        • Sidi A
        • Soffer D
        • Freeman S
        • Cotev S.
        Experimental closed head injury in rats: mechanical, pathophysiological and neurological properties.
        Crit Care Med. 1988; 16: 258-265
        • Marmarou A
        • Tanaka K
        • Shulman K
        An improved gravimetric measure of cerebral edema.
        J Neurosurg. 1982; 56: 246-253
        • Nelson RS
        • Mantz ML
        • Maxwell J.A.
        Use of specific gravity in the measurement of cerebral edema.
        J Appl Physiol. 1971; 30: 268-271
        • Shohami E
        • Rosenthal J
        • Lavy S.
        The effect of incomplete cerebral ischemia on prostaglandin levels in rat brain.
        Stroke. 1982; 13: 494-498
        • Lowry OH
        • Rosebrough NH
        • Farr AL
        • Randall R.J.
        Protein measurement with the folin phenol reagent.
        J Biol Chem. 1951; 193: 265-275
        • Shohami E
        • Gross J.
        An ex vivo method for evaluating prostaglandin synthetase activity in cortical slices of mouse brain.
        J Neurochem. 1985; 45: 132-136
        • Shohami E
        • Jacobs TP
        • Hallenbeck JM
        • Feuerestein G.
        Increased thromboxane and 5-HETE production following spinal cord ischemia in the rabbit.
        Prostaglandins Leukotrienes and Medicine. 1987; 28: 169-181
        • Dempsey RJ
        • Roy MW
        • Meyer K
        • Cowen DE
        • Tai H.
        Development of cyclooxygenase and lipoxygenase metabolites of arachidonic acid after transient cerebral ischemia.
        J Neurosurg. 1986; 64: 118-124
        • Roy MW
        • Dempsey RJ
        • Cowen DE
        • Donaldson DL
        • Young AD
        Thromboxane synthetase inhibition with imidazole increases blood flow in ischemic penumbra. 1988; 22: 317-323
        • Ishihara G
        • Uchida Y
        • Kitamura S.
        Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs.
        Prostaglandins Leukotrienes and Medicine. 1986; 21: 197-206
        • Nihei C
        • Shimanaka Y
        • Kawahara R
        • Komatsu O
        • et al.
        Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis.
        in: 6th International Conference on Prostaglandins and related compounds, Florence, Italy1986: 410
        • Latchaw JP
        • Capraro J
        • Moufarrij N
        • Reedy DP
        • Lesser RP
        • Slugg RM
        • Cook AF
        • Stowe N
        • Skrinska V
        • Lucas F
        • Little R.J.
        The effects of verapamil, thromboxane synthetase inhibitor, chlorpromazine and propranolol in acute focal cerebral ischemia.
        J Cerebr Blood Flow Metabol. 1983; 3: S367-S368
        • Lelcuk S
        • Alexander FA
        • Kobzik L
        • et al.
        Prostacyclin and thromboxane A2 moderate post ischemic renal failure.
        Surgery. 1985; 98: 207-212
        • Tobimatzu M
        • Toyoda K
        • Saito S
        • Ueda Y
        • Konomi K.
        Effect of a stable prostacyclin analogue on canine renal allograft rejection.
        Ann Surg. 1987; 205: 199-202
        • Edmonds LC
        • Lefer AM.
        Protective actions of a new thromboxane synthetase inhibitor in arachidonate induced sudden death.
        Life Sci. 1984; 35: 1763-1768